Optimal timing of thoracic irradiation for limited stage small cell lung cancer:Current evidence and future prospects
作者机构:Gulhane Medical Faculty Department of Radiation OncologyUniversity of Health SciencesAnkara 0090Turkey
出 版 物:《World Journal of Clinical Oncology》 (世界临床肿瘤学杂志(英文版))
年 卷 期:2022年第13卷第2期
页 面:116-124页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:Small cell lung cancer Thoracic irradiation Limited stage small cell lung cancer Timing of thoracic radiation therapy Thoracic radiation therapy
摘 要:Lung cancer is a global health concern as the leading cause of cancer related mortality *** cell lung cancer(SCLC)poses a formidable challenge to the treating physicians with the worst prognosis among all lung ***,limited stage SCLC(LS-SCLC)has a relatively better outcome with multimodality *** have been focused on optimal integration of treatment modalities to achieve an improved therapeutic ratio for patients with *** chemotherapy and thoracic radiation therapy(TRT)are primary components of initial management for LS-SCLC,there is no consensus on optimal timing of *** this context,we herein provide a concise overview of current evidence and future prospects regarding the optimal timing of thoracic irradiation for LS-SCLC in light of the literature.